Understanding patient needs in switching from biologic to biosimilar medicines: final report of survey and focus group findings

This report raises concerns about patients ' experiences of being switched onto biosimilar medicines from their existing biologics. It finds patients are not always receiving the support they need to understand any changes, or to monitor and manage side effects or other adverse consequences

Source: Current Awareness Service for Health (CASH) - January 3, 2019 Category: Consumer Health News Source Type: news